Overview
Youmin Shin practices practicing medicine in Seoul, Republic of Korea.
Their clinical expertise encompasses Epilepsy, Cortical Dysplasia, Colorectal Cancer, Seizures, and Colonoscopy.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Youmin Shin
Is Youmin Shin a top-rated expert for Epilepsy?
MediFind is an objective health platform that identifies experts based on real-world data. Youmin Shin is classified as an Experienced expert for Epilepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Youmin Shin participate in research or clinical trials?
Yes. Youmin Shin has published 18 articles and abstracts on conditions like Epilepsy. You can view a list of Youmin Shin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ColonoscopyShin isExperienced. Learn about Colonoscopy.
- Colorectal CancerShin isExperienced. Learn about Colorectal Cancer.
- Cortical DysplasiaShin isExperienced. Learn about Cortical Dysplasia.
- EpilepsyShin isExperienced. Learn about Epilepsy.
- SeizuresShin isExperienced. Learn about Seizures.